Literature DB >> 16689410

Indicators of poor quality end-of-life cancer care in Ontario.

Lisa Barbera1, Lawrence Paszat, Carole Chartier.   

Abstract

This study measures the proportion of cancer patients in Ontario, Canada, with intensive care unit (ICU) admissions, emergency room (ER) visits, or chemotherapy in the last two weeks of life. We used the Ontario Cancer Registry to identify a cohort of cancer patients who died in 2001. These cases were then linked to administrative sources of data to measure each indicator, and to describe the associated clinical and health service factors. In the cohort, 27% had at least one ER visit and 5% had an ICU visit in the last two weeks of life. Of those who received chemotherapy in the last six months, 16% received chemotherapy in the last two weeks of life. Receiving a home care visit in the last six months of life, or a physician house call or a palliative care assessment in the last two weeks of life was consistently associated with decreased odds of each of the indicators. Our results indicate that a significant proportion of Ontario cancer patients have indicators of poor quality end-of-life care. Certain health care factors may influence these indicators.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16689410

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  74 in total

1.  Predictors of home care expenditures and death at home for cancer patients in an integrated comprehensive palliative home care pilot program.

Authors:  Doris M Howell; Tom Abernathy; Rhonda Cockerill; Kevin Brazil; Frank Wagner; Larry Librach
Journal:  Healthc Policy       Date:  2011-02

2.  Why do patients with cancer visit the emergency department near the end of life?

Authors:  Lisa Barbera; Carole Taylor; Deborah Dudgeon
Journal:  CMAJ       Date:  2010-03-15       Impact factor: 8.262

3.  Quality of end-of-life cancer care in Canada: a retrospective four-province study using administrative health care data.

Authors:  L Barbera; H Seow; R Sutradhar; A Chu; F Burge; K Fassbender; K McGrail; B Lawson; Y Liu; R Pataky; A Potapov
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

4.  [Palliative care and end-of-life patients in emergency situations. Recommendations on optimization of out-patient care].

Authors:  C H R Wiese; D A Vagts; U Kampa; G Pfeiffer; I-U Grom; M A Gerth; B M Graf; Y A Zausig
Journal:  Anaesthesist       Date:  2011-02       Impact factor: 1.041

5.  Factors Associated with End-of-Life Health Service Use in Patients Dying of Cancer.

Authors:  Lisa Barbera; Jonathan Sussman; Raymond Viola; Amna Husain; Doris Howell; S Lawrence Librach; Hugh Walker; Rinku Sutradhar; Carole Chartier; Lawrence Paszat
Journal:  Healthc Policy       Date:  2010-02

6.  Timing of code status documentation and end-of-life outcomes in patients admitted to an oncology ward.

Authors:  Amanda Caissie; Nanor Kevork; Breffni Hannon; Lisa W Le; Camilla Zimmermann
Journal:  Support Care Cancer       Date:  2014-02       Impact factor: 3.603

7.  Chemotherapy in the last 30 days of life of advanced cancer patients.

Authors:  Paola Pacetti; Giovanni Paganini; Massimo Orlandi; Andrea Mambrini; M Cristina Pennucci; Alfonso Del Freo; Maurizio Cantore
Journal:  Support Care Cancer       Date:  2015-04-22       Impact factor: 3.603

8.  Can the introduction of an integrated service model to an existing comprehensive palliative care service impact emergency department visits among enrolled patients?

Authors:  Beverley J Lawson; Frederick I Burge; Paul McIntyre; Simon Field; David Maxwell
Journal:  J Palliat Med       Date:  2009-03       Impact factor: 2.947

9.  Radiation therapy in the last month of life.

Authors:  Anand Patel; Jacquelyn Dunmore-Griffith; Stephen Lutz; Peter A S Johnstone
Journal:  Rep Pract Oncol Radiother       Date:  2013-10-16

10.  [Emergency outpatient palliative care in acute situations by paramedics].

Authors:  Christoph H R Wiese; Utz Bartels; David Ruppert; Hartwig Marung; Bernhard M Graf; Gerd G Hanekop
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.